Li was the recipient of the 2022 Future Science Prize in the Life Sciences, awarded for establishing sodium taurocholate cotransporting polypeptide (NTCP) as the receptor of hepatitis B and D in humans. This breakthrough discovery has positive implications for the future of designing therapeutics for these viral diseases.

(Photo: Future Science Prize)